Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sygnature Discovery
Biotech
Neumora overhauls C-suite after phase 3 flop—Chutes & Ladders
Neumora overhauls C-suite after phase 3 flop. Lycia lands veteran CMO. Navigator arrives at new CEO.
Darren Incorvaia
,
Zoey Becker
Feb 14, 2025 8:30am
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Oct 18, 2024 8:30am
Sygnature Discovery pumps £3.75M into data management system
Nov 8, 2023 3:10pm
Sygnature Discovery acquires Canadian CRO NuChem Sciences
Aug 3, 2023 8:10am
Sygnature Discovery buys Peak Proteins to bolster drug discovery
Apr 27, 2022 7:00am
Sygnature Discovery snaps up fellow British CRO XenoGesis
Sep 29, 2020 7:45am
